OrsoBio

View 5 free companies with a free account

Get full access to valuations, team members, funding history, and investor details.

Investors

Venture capital firms, private equity investors, and strategic partners

Investor	Type
Ascenta Capital	N/A
Eli Lilly	N/A
Enavate Sciences	N/A
Longitude Capital	Venture Capital
National Institute of Diabetes and Digestive and Kidney Diseases	N/A

+3 More Investors Available

Types of Investors

OrsoBio has attracted various types of institutional and strategic investors

Common Investor Types

•Venture Capital Firms: Early-stage and growth equity investors
•Private Equity: Later-stage institutional investors
•Strategic Investors: Corporations in related industries
•Angel Investors: High-net-worth individuals
•Family Offices: Private wealth management firms

What Investors Provide

✓Capital for growth and expansion
✓Strategic guidance and expertise
✓Industry connections and partnerships
✓Market validation and credibility
✓Board representation and governance

Who Invested in OrsoBio?

OrsoBio has attracted investment from 8+ venture capital firms, private equity investors, and strategic partners across 0 funding rounds. These investors have provided a total of $166.6M in capital to fuel the company's growth.

Why Do Investors Fund OrsoBio?

Investors are attracted to OrsoBio due to the company's strong market position, growth potential, and proven business model. The company's current valuation of $310M reflects investor confidence in its ability to generate returns through continued growth, potential IPO, or strategic acquisition.

Types of OrsoBio Investors

OrsoBio investors typically include a mix of venture capital firms providing growth capital, private equity firms for later-stage funding, strategic corporate investors from related industries, and high-net-worth angel investors. Each investor type brings unique value beyond capital, including industry expertise, strategic partnerships, and operational guidance.

Investor FAQs

How many investors does OrsoBio have?

OrsoBio has had 8+ investors participate across its funding rounds. This includes venture capital firms, private equity investors, strategic partners, and angel investors.

Who are the lead investors in OrsoBio?

Lead investors typically invest the largest amounts and often take board seats. For detailed information about OrsoBio's lead investors and cap table structure, please contact our team.

Can I become an investor in OrsoBio?

Accredited investors can purchase OrsoBio shares on the secondary market through Premier Alternatives. This provides an opportunity to invest in the company before a potential IPO or acquisition event.